Telephone-Based Re-education for Hp Eradication
NCT03193450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162
Last updated 2018-05-30
Summary
It was suggested that the patient compliance plans an important role in the Hp eradication. However, data on whether re-education could improve the eradication rate are lacking. We consider that re-education on patients by telephone during the process of drug administration could increase the eradication rate in Hp infected patients.
We hypothesized that telephone re-education during the whole process of drug administration would improve the compliance of patients and ultimately increase the Hp eradication rate.
Conditions
- Helicobacter Pylori Infection
Interventions
- BEHAVIORAL
-
telephone-based re-education
Patients will receive a repeated instruction by telephone in terms of both calling and message at the forth, seventh, tenth day after the start of treatment.
- BEHAVIORAL
-
First education at the clinic
Patients will receive an instruction card about the drug administration at the clinic by doctors.
Sponsors & Collaborators
-
First Affiliated Hospital Xi'an Jiaotong University
lead OTHER
Principal Investigators
-
Shuixiang He, MD, PhD · First Affiliated Hospital Xi'an Jiaotong University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-18
- Primary Completion
- 2018-03-30
- Completion
- 2018-03-30
Countries
- China
Study Locations
More Related Trials
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
High-dose Dual Therapy with Different Administration Frequencies
NCT05901051 ·Status: COMPLETED ·Phase: PHASE4
-
Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.
NCT04107194 ·Status: UNKNOWN ·Phase: PHASE3
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
NCT03365609 ·Status: RECRUITING ·Phase: NA
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT03658746 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
NCT01163435 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
NCT02483715 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori
NCT02349685 ·Status: COMPLETED ·Phase: NA
-
High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)
NCT07121205 ·Status: COMPLETED
-
A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
NCT02689583 ·Status: UNKNOWN ·Phase: NA
-
Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment
NCT02935010 ·Status: COMPLETED ·Phase: PHASE4
-
Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
NCT03556254 ·Status: UNKNOWN ·Phase: PHASE4
-
Resistance of Helicobacter Pylori to Antibiotics in Children
NCT01902589 ·Status: COMPLETED
-
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
NCT03616405 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication
NCT06723197 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
NCT03897244 ·Status: COMPLETED ·Phase: PHASE4
-
14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection
NCT05438550 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT05332444 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
NCT05620589 ·Status: UNKNOWN
-
Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Care
NCT05090475 ·Status: COMPLETED ·Phase: NA
-
Helicobacter Pylori Resistance
NCT05019586 ·Status: COMPLETED